Lv0
0 积分 2025-06-03 加入
A Real-World Disproportionality Analysis of Olaparib: Data Mining of the Public Version of FDA Adverse Event Reporting System
10小时前
已完结
Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database
12小时前
已完结
Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature
12小时前
已完结
Clinical and radiological pattern of olaparib-induced interstitial lung disease
13小时前
已关闭
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance
13小时前
已完结
Research on the correlation of immunity in patients with chronic insomnia
11天前
已完结
Epidemiological survey of hypertension among middle-aged and elderly adults in Anhui Province
11天前
已完结
皖公网安备34019202002308
